Conference Coverage

New insights emerge from pediatric chronic cutaneous lupus


 

AT THE SPD ANNUAL MEETING

References

"I love this study," commented SPD President Dr. Beth A. Drolet, professor of dermatology at the Medical College of Wisconsin, Milwaukee. "Your point that if transformation to SLE happens, it’s going to happen quickly – that’s enormously helpful to me clinically."

The study was funded by the SPD. Dr. Arkin reported having no financial conflicts.

bjancin@frontlinemedcom.com

Pages

Recommended Reading

Tool predicts lymphoma, death in primary Sjögren’s syndrome patients
MDedge Internal Medicine
Eurofever Project takes aim at rare autoinflammatory disorders
MDedge Internal Medicine
Live births seen in half of pregnancies exposed to belimumab
MDedge Internal Medicine
VIDEO: Slow tapering worked best for stopping SLE immunosuppression
MDedge Internal Medicine
SLE patients in remission safely stop immunotherapy
MDedge Internal Medicine
Increased risk of heart attack confirmed in Sjögren’s syndrome patients
MDedge Internal Medicine
Real-world use supports belimumab clinical trial data
MDedge Internal Medicine
Trial of sirukumab for lupus nephritis falls flat
MDedge Internal Medicine
Deaths mar atacicept trial for lupus, but research continues
MDedge Internal Medicine
Rituximab yielded long-term benefit in lupus nephritis
MDedge Internal Medicine